Profound Medical Corp. (PROF) Tops Q3 EPS by 64c

Profound Medical Corp. (NASDAQ: PROF) reported Q3 EPS of $0.26, $0.64 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $5.03 million versus the consensus estimate of $4.76 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.

You May Also Be Interested In

• Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
• Meritage Hospitality posts Q2 loss amid restructuring charges
• Penguin Solutions closes $750M convertible notes offering due 2031